Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids.
about
Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomicsLoss of Swiss cheese/neuropathy target esterase activity causes disruption of phosphatidylcholine homeostasis and neuronal and glial death in adult Drosophila.Srf1 is a novel regulator of phospholipase D activity and is essential to buffer the toxic effects of C16:0 platelet activating factorGallic acid ameliorated impaired glucose and lipid homeostasis in high fat diet-induced NAFLD miceMetabolomics tools for describing complex pesticide exposure in pregnant women in Brittany (France)A polyamine-deficient diet prevents oxaliplatin-induced acute cold and mechanical hypersensitivity in ratsA neurotoxic glycerophosphocholine impacts PtdIns-4, 5-bisphosphate and TORC2 signaling by altering ceramide biosynthesis in yeastSecreted phospholipase A2 involvement in neurodegeneration: differential testing of prosurvival and anti-inflammatory effects of enzyme inhibitionUsing neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease.Relationship between fractional anisotropy of cerebral white matter and metabolite concentrations measured using (1)H magnetic resonance spectroscopy in healthy adults.Magnetic resonance spectroscopy in Alzheimer's disease.Tissue-specific metabolic responses of Cyprinus flammans to copper.Magnetic Resonance Spectroscopy in Alzheimer's Disease: Systematic Review and Meta-Analysis.Diagnostic methods for extra-temporal neocortical focal epilepsies: present and future.Role of secretory phospholipase a(2) in CNS inflammation: implications in traumatic spinal cord injury.Metabolic and transmitter changes in core and penumbra after middle cerebral artery occlusion in miceThe functional organisation of glia in the adult brain of Drosophila and other insects.Matrix effects in biological mass spectrometry imaging: identification and compensation.Multi-dimensional mass spectrometry-based shotgun lipidomics and the altered lipids at the mild cognitive impairment stage of Alzheimer's disease.Quantitative proton magnetic resonance spectroscopy detects abnormalities in dorsolateral prefrontal cortex and motor cortex of patients with frontotemporal lobar degenerationCombining diffusion tensor imaging and magnetic resonance spectroscopy to study reduced frontal white matter integrity in youths with family histories of substance use disorders.Short-term administration of uridine increases brain membrane phospholipid precursors in healthy adults: a 31-phosphorus magnetic resonance spectroscopy study at 4T.Early Alzheimer's disease neuropathology detected by proton MR spectroscopy.Comparison of inter subject variability and reproducibility of whole brain proton spectroscopy.Pea fiber and wheat bran fiber show distinct metabolic profiles in rats as investigated by a 1H NMR-based metabolomic approach.Aging-related Changes in Mouse Serum Glycerophospholipid ProfilesCytosolic phospholipase A2 protein as a novel therapeutic target for spinal cord injuryMagnetic resonance spectroscopy, β-amyloid load, and cognition in a population-based sample of cognitively normal older adults.Secretory phospholipase A2 IIA is up-regulated by TNF-alpha and IL-1alpha/beta after transient focal cerebral ischemia in rat.Role of GABAergic antagonism in the neuroprotective effects of bilobalide.Cytidine 5'-diphosphocholine (CDP-choline) in stroke and other CNS disordersInflammation & apoptosis in spinal cord injuryThalamic Involvement in Fluctuating Cognition in Dementia with Lewy Bodies: Magnetic Resonance EvidencesDietary Omega-3 Fatty Acids Do Not Change Resistance of Rat Brain or Liver Mitochondria to Ca(2+) and/or Prooxidants.Plasma 24-metabolite Panel Predicts Preclinical Transition to Clinical Stages of Alzheimer's DiseaseA UPLC/MS-based metabolomics investigation of the protective effect of ginsenosides Rg1 and Rg2 in mice with Alzheimer's diseasePotential Adverse Effects of Prolonged Sevoflurane Exposure on Developing Monkey Brain: From Abnormal Lipid Metabolism to Neuronal DamageLipids and the pathogenesis of Alzheimer's disease: is there a link?Aerobic fitness and the brain: increased N-acetyl-aspartate and choline concentrations in endurance-trained middle-aged adultsPsychiatric symptoms correlate with metabolic indices in the hippocampus and cingulate in patients with mitochondrial disorders.
P2860
Q21560953-A676249D-881B-438C-AA9F-763168FCDD67Q24534186-673DA43F-0471-4068-9841-481DB3DC96C2Q24627548-BE1DEC6B-65BF-4654-BA8C-8437231A4262Q27333713-03665DA2-968B-497F-91F3-FAB65661F4A2Q28383230-FF021204-0C69-4D79-B205-0CB31AC4837FQ28534748-5208E858-C2AB-4F21-823C-77C382889EDDQ28539054-C37E3180-018A-4F67-85A4-94977A887CF2Q28728398-D3448CB7-DBA9-414F-B83F-E6B08AF7AFA9Q30451918-C5FB457A-1705-4D4A-9AD4-CEEA2D1A7665Q30573753-2DEC88D0-0EB6-4557-8273-0DC490300DC5Q30630699-CFB57355-802D-44B1-A334-6302CB9993AFQ30920391-7EDDF891-8F19-45C0-9B77-523836EA1F5FQ30996805-A4B191E4-B0D6-4F05-AFD3-5B10B5752579Q33546410-7747073A-86DE-4B20-BB2F-2BAF3F101A3DQ33565825-CB03C27D-16CE-4088-B957-382B0BE1FCE0Q33615677-66A7FF9C-8373-460B-964B-DF75F5072A5FQ33760874-3551FB6F-5A4C-41B8-BDD1-6D79D8803C60Q33835517-3F490118-AF60-4235-B6F9-CE5A7324EEBBQ33915435-1AC98B0D-383B-44A8-AABD-AEEC5CCE40E6Q34053435-5633B67A-3033-4CA8-ABA7-17A399648552Q34448709-E184ADFB-5C11-41AA-BFFA-40A6D84BF921Q34488173-0E3AEA0A-4343-4690-9BE3-71BE5C076CE9Q34614543-7C3056DE-BB1A-4BB7-9ABD-A16B9CB2FB6CQ34724733-7D8625A9-FE1E-4410-8D04-16D18D7D51CAQ34776333-227B8D3C-A4F9-4301-A088-CCD00A417D01Q34800397-CB3FF027-49CA-45D2-A705-4C94230A30F6Q35061098-2C3C1403-D267-4799-8853-C4A216D00BA4Q35210272-7695A990-52B4-40CB-BD3D-E646405BD93DQ35757950-7874F4FA-831C-46D2-977B-05F142AAF19EQ35781917-56BF1BD9-C607-4DB4-A422-76D0F6E957C5Q35915801-3CC3C754-6E02-40DB-B269-92BCDD7AE2DBQ35993239-98618DC2-8E81-4D07-93DE-2B323BCDEDF4Q36098778-7C97291B-6126-40B9-889E-72E0E6BD19C8Q36210621-E102DD93-1380-4FA3-97EE-9A7170F0A776Q36272443-13CCD68F-C4DC-47A0-B49A-0FE0CCF32DA0Q36437878-2B80CCC5-FB55-4610-B5A2-95F441DC61F7Q36448037-F860CB67-BA3F-4126-8DDA-9FAA9C94151FQ36508071-FB64F824-62C9-4662-8361-EA0A28F31FD0Q36511178-2BCE13D2-5B97-4A9E-A4A2-5031AF9B18E6Q36591226-B9E74D11-D9CA-497B-A08D-5156C520F683
P2860
Membrane breakdown in acute and chronic neurodegeneration: focus on choline-containing phospholipids.
description
2000 nî lūn-bûn
@nan
2000 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Membrane breakdown in acute an ...... line-containing phospholipids.
@ast
Membrane breakdown in acute an ...... line-containing phospholipids.
@en
type
label
Membrane breakdown in acute an ...... line-containing phospholipids.
@ast
Membrane breakdown in acute an ...... line-containing phospholipids.
@en
prefLabel
Membrane breakdown in acute an ...... line-containing phospholipids.
@ast
Membrane breakdown in acute an ...... line-containing phospholipids.
@en
P356
P1476
Membrane breakdown in acute an ...... line-containing phospholipids.
@en
P2093
P2888
P304
P356
10.1007/S007020070051
P577
2000-01-01T00:00:00Z